1. Home
  2. DEI vs BHVN Comparison

DEI vs BHVN Comparison

Compare DEI & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Douglas Emmett Inc.

DEI

Douglas Emmett Inc.

N/A

Current Price

$9.98

Market Cap

1.9B

Sector

Real Estate

ML Signal

N/A

Logo Biohaven Ltd.

BHVN

Biohaven Ltd.

N/A

Current Price

$15.34

Market Cap

2.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DEI
BHVN
Founded
1971
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.1B
IPO Year
2006
2022

Fundamental Metrics

Financial Performance
Metric
DEI
BHVN
Price
$9.98
$15.34
Analyst Decision
Hold
Buy
Analyst Count
12
17
Target Price
$12.40
★ $23.73
AVG Volume (30 Days)
1.9M
★ 2.9M
Earning Date
11-03-2026
10-29-2026
Dividend Yield
★ 7.50%
N/A
EPS Growth
N/A
★ 26.08
EPS
★ N/A
N/A
Revenue
★ $1,003,982,000.00
N/A
Revenue This Year
$1.79
N/A
Revenue Next Year
$2.61
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 1.77
N/A
52 Week Low
$9.04
$7.48
52 Week High
$12.97
$18.24

Technical Indicators

Market Signals
Indicator
DEI
BHVN
Relative Strength Index (RSI) 50.77 63.07
Support Level $9.24 $13.56
Resistance Level $10.10 $16.85
Average True Range (ATR) 0.26 1.00
MACD 0.08 0.40
Stochastic Oscillator 73.56 88.87

Price Performance

Historical Comparison
DEI
BHVN

About DEI Douglas Emmett Inc.

Douglas Emmett Inc is an integrated, self-administered, and self-managed REIT. The group focuses on owning, acquiring, developing, and managing a substantial market share of office properties and multifamily communities in neighborhoods with supply constraints, high-end executive housing, and key lifestyle amenities. Its properties are located in the Beverly Hills, Brentwood, Burbank, Century City, Olympic Corridor, Santa Monica, Sherman Oaks/Encino, Warner Center/Woodland Hills and Westwood submarkets of Los Angeles County, California, and in Honolulu, Hawaii. It has two business segments: the office segment and multifamily segment, of which Office segment derives maximum revenue.

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.

Share on Social Networks: